Sodium arsenite exposure inhibits histone acetyltransferase p300 for attenuating H3K27ac at enhancers in mouse embryonic fibroblast cells

[1]  Heqing Shen,et al.  Arsenic activates the expression of 3&bgr;‐HSD in mouse Leydig cells through repression of histone H3K9 methylation , 2017, Toxicology and applied pharmacology.

[2]  Weiqun Peng,et al.  MLL3/MLL4 are required for CBP/p300 binding on enhancers and super-enhancer formation in brown adipogenesis , 2017, Nucleic acids research.

[3]  M. Rea,et al.  Epigenomic reprogramming in inorganic arsenic-mediated gene expression patterns during carcinogenesis , 2017, Reviews on environmental health.

[4]  R. Grafström,et al.  Arsenic alters global histone modifications in lymphocytes in vitro and in vivo , 2016, Cell Biology and Toxicology.

[5]  Dustin E. Schones,et al.  Distinct roles of DNMT1-dependent and DNMT1-independent methylation patterns in the genome of mouse embryonic stem cells , 2015, Genome Biology.

[6]  J. Baron,et al.  Arsenic and Lung Disease Mortality in Bangladeshi Adults , 2014, Epidemiology.

[7]  E. Guallar,et al.  Association of Global DNA Methylation and Global DNA Hydroxymethylation with Metals and Other Exposures in Human Blood DNA Samples , 2014, Environmental health perspectives.

[8]  Zhibin Wang,et al.  Histone Modification Patterns and Their Responses to Environment , 2014, Current Environmental Health Reports.

[9]  J. Mill,et al.  Epigenetic studies in Alzheimer's disease: Current findings, caveats, and considerations for future studies , 2013, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[10]  Yiguo Jiang,et al.  Epithelial to mesenchymal transition in arsenic-transformed cells promotes angiogenesis through activating β-catenin-vascular endothelial growth factor pathway. , 2013, Toxicology and applied pharmacology.

[11]  R. Roeder,et al.  SET1 and p300 Act Synergistically, through Coupled Histone Modifications, in Transcriptional Activation by p53 , 2013, Cell.

[12]  M. Banerjee,et al.  Role of genomic instability in arsenic-induced carcinogenicity. A review. , 2013, Environment international.

[13]  J. Schug,et al.  Genome-Wide Alteration of Histone H3K9 Acetylation Pattern in Mouse Offspring Prenatally Exposed to Arsenic , 2013, PloS one.

[14]  Max Costa,et al.  Carcinogenic metals and the epigenome: understanding the effect of nickel, arsenic, and chromium. , 2012, Metallomics : integrated biometal science.

[15]  Li-Rong Yu,et al.  Distinct roles of GCN5/PCAF‐mediated H3K9ac and CBP/p300‐mediated H3K18/27ac in nuclear receptor transactivation , 2011, The EMBO journal.

[16]  B. Langmead,et al.  Aligning Short Sequencing Reads with Bowtie , 2010, Current protocols in bioinformatics.

[17]  R. Young,et al.  Histone H3K27ac separates active from poised enhancers and predicts developmental state , 2010, Proceedings of the National Academy of Sciences.

[18]  P. Möller,et al.  KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma. , 2010, Blood.

[19]  A. Burlingame,et al.  Acetylated H4K16 by MYST1 protects UROtsa cells from arsenic toxicity and is decreased following chronic arsenic exposure. , 2009, Toxicology and applied pharmacology.

[20]  Dustin E. Schones,et al.  Genome-wide Mapping of HATs and HDACs Reveals Distinct Functions in Active and Inactive Genes , 2009, Cell.

[21]  Dustin E. Schones,et al.  Characterization of human epigenomes. , 2009, Current opinion in genetics & development.

[22]  Donna D. Zhang,et al.  Acetylation of Nrf2 by p300/CBP Augments Promoter-Specific DNA Binding of Nrf2 during the Antioxidant Response , 2009, Molecular and Cellular Biology.

[23]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[24]  Michael Q. Zhang,et al.  Combinatorial patterns of histone acetylations and methylations in the human genome , 2008, Nature Genetics.

[25]  T. Ramírez,et al.  Sodium arsenite modulates histone acetylation, histone deacetylase activity and HMGN protein dynamics in human cells , 2008, Chromosoma.

[26]  X. Chen,et al.  Krüppel-like Factor 4 Is Acetylated by p300 and Regulates Gene Transcription via Modulation of Histone Acetylation* , 2007, Journal of Biological Chemistry.

[27]  Dustin E. Schones,et al.  High-Resolution Profiling of Histone Methylations in the Human Genome , 2007, Cell.

[28]  K. Zierold,et al.  Association of arsenic-contaminated drinking-water with prevalence of skin cancer in Wisconsin's Fox River Valley. , 2006, Journal of health, population, and nutrition.

[29]  B. Chait,et al.  Synergistic Functions of SII and p300 in Productive Activator-Dependent Transcription of Chromatin Templates , 2006, Cell.

[30]  Lawryn H Kasper,et al.  Conditional Knockout Mice Reveal Distinct Functions for the Global Transcriptional Coactivators CBP and p300 in T-Cell Development , 2006, Molecular and Cellular Biology.

[31]  Johan T den Dunnen,et al.  Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. , 2005, American journal of human genetics.

[32]  C. Caldas,et al.  p300/CBP and cancer , 2004, Oncogene.

[33]  V. Yang,et al.  Identification of Krüppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer , 2004, Oncogene.

[34]  P. Nambiar,et al.  p53 and its co-activator p300 are inversely regulated in the mouse colon in response to carcinogen. , 2003, Toxicology letters.

[35]  Kazuo T. Suzuki,et al.  Arsenic round the world: a review. , 2002, Talanta.

[36]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[37]  D. Livingston,et al.  Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. , 2000, Genes & development.

[38]  D. Menzel,et al.  Arsenic disrupts cellular levels of p53 and mdm2: a potential mechanism of carcinogenesis. , 1999, Biochemical and biophysical research communications.

[39]  T. Suda,et al.  Mice homozygous for a truncated form of CREB-binding protein exhibit defects in hematopoiesis and vasculo-angiogenesis. , 1999, Blood.

[40]  B. Diwan,et al.  Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[41]  B. Howard,et al.  The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases , 1996, Cell.

[42]  T. Kaise,et al.  Induction of chromosomal aberrations in cultured human fibroblasts by inorganic and organic arsenic compounds and the different roles of glutathione in such induction. , 1996, Mutation research.

[43]  J B Lawrence,et al.  Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. , 1994, Genes & development.

[44]  C. Chen,et al.  Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. , 1989, American journal of epidemiology.

[45]  A. Mirsky,et al.  Structural Modifications of Histones and their Possible Role in the Regulation of RNA Synthesis. , 1964, Science.

[46]  U. Boggi,et al.  Tumorigenesis and Neoplastic Progression KLF 4 is a Novel Candidate Tumor Suppressor Gene in Pancreatic Ductal Carcinoma , 2010 .

[47]  Xianglin Shi,et al.  Oxidative mechanism of arsenic toxicity and carcinogenesis , 2004, Molecular and Cellular Biochemistry.

[48]  H. Drexler,et al.  The Pearson product‐moment correlation coefficient is better suited for identification of DNA fingerprint profiles than band matching algorithms , 1993, Electrophoresis.